celecoxib has been researched along with Adenocarcinoma of Lung in 1 studies
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, C | 2 |
| Li, X | 1 |
| Zhang, D | 1 |
| Xu, B | 1 |
| Hu, W | 1 |
| Zheng, X | 1 |
| Zhu, D | 1 |
| Zhou, Q | 1 |
| Jiang, J | 1 |
1 other study available for celecoxib and Adenocarcinoma of Lung
| Article | Year |
|---|---|
IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUAD.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Animals; Antagomirs; Celecoxib; Cel | 2018 |